Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $471.34)
- $471.34 P/E (TTM): 33.01X Cap: $118.13B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $467.03)
- $467.03 P/E (TTM): 65.62X Cap: $169.76B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $471.34)
- $471.34 P/E (TTM): 33.01X Cap: $118.13B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $211.14)
- $211.14 P/E (TTM): 172.24X Cap: $398.82B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $234.55)
- $234.55 P/E (TTM): 22.27X Cap: $561.60B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,076.82)
- $1,076.82 P/E (TTM): 51.08X Cap: $948.65B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $118.25)
- $118.25 P/E (TTM): 14.99X Cap: $287.51B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $173.74)
- $173.74 P/E (TTM): 20.63X Cap: $8.60B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $631.74)
- $631.74 P/E (TTM): 50.72X Cap: $50.51B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $76.90)
- $76.90 P/E (TTM): 15.67X Cap: $8.99B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $102.27)
- $102.27 P/E (TTM): 17.55X Cap: $19.81B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $25.01)
- $25.01 P/E (TTM): 14.53X Cap: $3.09B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $29.51)
- $29.51 P/E (TTM): 376.03X Cap: $239.83B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $471.34)
- $471.34 P/E (TTM): 33.01X Cap: $118.13B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $51.74)
- $51.74 Cap: $4.95B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $471.34)
- $471.34 P/E (TTM): 33.01X Cap: $118.13B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025